Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Monsanto enters into licensing contract with Marina
The companies kept the terms of the agreement confidential. Marina Biotech president and chief executive officer Michael French said, "We view this license as yet another important validation
The companies kept the terms of the agreement confidential. Marina Biotech president and chief executive officer Michael French said, "We view this license as yet another important validation
The generic version of Pfizer’s Lipitor is indicated for the treatment of hypercholesterolaemia and to prevent cardiovascular disease. The company is launching the product in Teva 360 livery,
The funds will aid in the development of compounds that act on the motor circuitry that is compromised in Parkinson’s disease (PD) through the modulation of a receptor
The cloud-based Mobile Intelligence enables the pharma company to achieve better governance through deeper system controls for cost, scalability and configuration. Cegedim’s OneKey, the global healthcare professional (HCP)
The platform provides an electronic laboratory notebook for chemistry and biology experiments, the capacity to query and report research data, and to visualize with chemical intelligence. Basilea CSO
The packaging solution is based on a thermoforming packaging machine with a new machine concept designed for applications which requires a high degree of flexibility. In the new
With significantly more patients treated with pasireotide LAR (31.3%) experiencing full control of their disease than those taking octreotide LAR (19.2%) (p=0.007), the study met its primary endpoint.
Hospira will distribute Foscavir to US patients on an emergency supply basis in September 2011. Clinigen Group chief executive Peter George said, "We’ve already established good penetration across
According to the agreement, HBI gains manufacturing rights of plasma-derived biopharmaceuticals using ProMetic proprietary PPPS. The collaboration will focus on the co-development and co-exclusive commercialization, on a world-wide
The non-invasive test uses a directed approach to analyze cell-free DNA (cfDNA) in maternal blood to detect common fetal trisomies, such as Trisomy 21 (associated with Down syndrome).